Polyvinyl alcohol microspheres, and injectable solutions of the same
View Patent ↗The present invention relates to microspheres useful for embolization which comprises polyvinylalcohol. The present invention also relates to an injectable suspension suitable for embolization which comprises the polyvinylalcohol microspheres and a suitable liquid carrier. The present invention further relates to a method for prophylactic or therapeutic embolization which comprises administering to a mammal an injectable suspension containing the polyvinylalcohol microspheres and a suitable liquid carrier. Finally, the present invention relates to a process for producing the polyvinylalcohol microspheres.
1. Microspheres useful for embolization, which comprise crosslinked polyvinylalcohol, wherein said microspheres (a) have a diameter ranging from about 10 μm to about 2,000 μm, (b) are substantially spherical, and (c) are sterile, and wherein aldehydes on said microspheres are neutralized by an aminoalcohol.
2. The microspheres of claim 1 wherein the diameter of said microspheres is in the range from about 50 μm to about 1,000 μm.
3. The microspheres of claim 1 wherein said microspheres further comprise a cell adhesion promoter.
4. The microspheres of claim 3 , wherein the cell adhesion promoter is selected from the group consisting of carboxymethyl (CM) dextran, collagen, DEAE dextran, gelatin, glucosaminoglycans, fibronectin, lectins, and polycations.
5. The microspheres of claim 4 wherein the cell adhesion promoter is selected from the group consisting of CM dextran, collagen and DEAE dextran.
6. The microspheres of claim 1 wherein said microspheres further comprise a marking agent.
7. The microspheres of claim 6 wherein the marking agent is selected from the group consisting of a dye, an imaging agent and a contrasting agent.
8. The microspheres of claim 1 , further comprising an anti-angiogenic agent.
9. An injectable sterile suspension suitable for embolization, which comprises: (a) the microspheres of claim 1 ; and (b) a suitable liquid carrier.
10. The injectable suspension of claim 9 , wherein the diameter of the microspheres are in the range from about 50 μm to about 1,000 μm.
11. The injectable suspension of claim 9 , wherein the microspheres are comprised of from about 0.5% to about 20% crosslinked polyvinylalcohol by weight in hydrogel form.
12. The injectable suspension of claim 9 , wherein the microspheres further comprise a cell adhesion promoter.
13. The injectable suspension of claim 12 , wherein the cell adhesion promoter is selected from the group consisting of CM dextran, collagen, DEAE dextran, gelatin, glucosaminoglycans, fibronectin, lectins, and polycations.
14. The injectable suspension of claim 9 , wherein the microspheres further comprise a marking agent.
15. The injectable suspension of claim 14 wherein the marking agent is selected from the group consisting of a dye, an imaging agent and a contrasting agent.
16. The injectable suspension of claim 9 , further comprising an anti-angiogenic agent.
17. The microspheres of claim 1 , wherein the microspheres are comprised of from about 0.5% to about 20% crosslinked polyvinylalcohol by weight in hydrogel form.
18. The microsphere of claim 3 , wherein the cell adhesion promoter is a natural biological cell adhesion promoter.
19. The microsphere of claim 3 , wherein the cell adhesion promoter is a synthetic biological cell adhesion promoter.
20. The injectable suspension of claim 12 , wherein the cell adhesion promoter is a natural biological cell adhesion promoter.
21. The injectable suspension of claim 12 , wherein the cell adhesion promoter is a synthetic biological cell adhesion promoter.
22. Microspheres useful for embolization, which comprise crosslinked polyvinylalcohol, wherein said microspheres (a) have a diameter ranging from about 10 μm to about 2,000 μm, (b) are substantially spherical, (c) are substantially uniform in size and shape, (d) are sterile and (e) are in the form of a dry powder, wherein aldehydes on said microspheres are neutralized by an aminoalcohol.
23. The microspheres of claim 22 , wherein the aminoalcohol is selected from the group consisting of Tris, 2-aminoethanol, aminosorbitol and glucosamine.
24. The microspheres of claim 1 , wherein the aminoalcohol is selected from the group consisting of Tris, 2-aminoethanol, aminosorbitol and glucosamine.
25. The microspheres of claim 1 , wherein the microspheres are substantially uniform in size.
26. The microspheres of claim 1 , wherein the microspheres are substantially uniform in shape.
27. The microspheres of claim 1 , wherein the microspheres are in the form of a dry powder.
28. The injectable suspension of claim 9 , wherein the microspheres are substantially uniform in size.
29. The injectable suspension of claim 9 , wherein the microspheres are substantially uniform in shape.